» Articles » PMID: 29693024

The Role of Flavonoids in Inhibiting Th17 Responses in Inflammatory Arthritis

Overview
Journal J Immunol Res
Publisher Wiley
Date 2018 Apr 26
PMID 29693024
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Flavonoids have been considered powerful anti-inflammatory agents, and their exact immunomodulatory action as therapeutic agents in autoimmune diseases has started to emerge. Their role in the manipulation of immunoregulation is less understood. Several studies attempted to investigate the role of various flavonoids mainly in experimental models of autoimmune diseases, especially in the context of their potential effect on the increase of regulatory T cells (Tregs) and their ability to stimulate an overexpression of anti-inflammatory cytokines, in particular that of IL-10. The emergence of IL-17, a cytokine largely produced by Th17 cells, as a powerful proinflammatory stimulus which attenuates the induction of Tregs has prompted a series of studies investigating the role of flavonoids on Th17 cells in experimental models as well as human autoimmune diseases. This review thoroughly discusses accumulated data on the role of flavonoids on Th17 in rheumatoid arthritis and experimental autoimmune arthritis.

Citing Articles

Assessment of oral toxicity of Lam aqueous extract and its effect on gout induced in a murine model.

Palomino-Pacheco M, Rojas-Armas J, Ortiz-Sanchez J, Arroyo-Acevedo J, Justil-Guerrero H, Martinez-Heredia J Vet World. 2024; 17(7):1449-1458.

PMID: 39185060 PMC: 11344109. DOI: 10.14202/vetworld.2024.1449-1458.


Unraveling the intricate dance of the Mediterranean diet and gut microbiota in autoimmune resilience.

Tsigalou C, Tsolou A, Stavropoulou E, Konstantinidis T, Zafiriou E, Dardiotis E Front Nutr. 2024; 11:1383040.

PMID: 38818135 PMC: 11137302. DOI: 10.3389/fnut.2024.1383040.


Redox Remodeling by Nutraceuticals for Prevention and Treatment of Acute and Chronic Inflammation.

Petrarca C, Viola D Antioxidants (Basel). 2023; 12(1).

PMID: 36670995 PMC: 9855137. DOI: 10.3390/antiox12010132.


Time to Deal with Rheumatoid Cachexia: Prevalence, Diagnostic Criteria, Treatment Effects and Evidence for Management.

Efthymiou E, Grammatikopoulou M, Gkiouras K, Efthymiou G, Zafiriou E, Goulis D Mediterr J Rheumatol. 2022; 33(3):271-290.

PMID: 36531417 PMC: 9727471. DOI: 10.31138/mjr.33.3.271.


Flavonoids as Potential Anti-Inflammatory Molecules: A Review.

Al-Khayri J, Sahana G, Nagella P, Joseph B, Alessa F, Al-Mssallem M Molecules. 2022; 27(9).

PMID: 35566252 PMC: 9100260. DOI: 10.3390/molecules27092901.


References
1.
Keller K, Lindgaard L, Wogensen L, Dagnaes-Hansen F, Thomsen J, Sakaguchi S . SKG arthritis as a model for evaluating therapies in rheumatoid arthritis with special focus on bone changes. Rheumatol Int. 2012; 33(5):1127-33. DOI: 10.1007/s00296-012-2500-7. View

2.
Lee J, Park W . Anti-inflammatory effects of oroxylin A on RAW 264.7 mouse macrophages induced with polyinosinic-polycytidylic acid. Exp Ther Med. 2016; 12(1):151-156. PMC: 4906705. DOI: 10.3892/etm.2016.3320. View

3.
Azizi G, Jadidi-Niaragh F, Mirshafiey A . Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis. Int J Rheum Dis. 2013; 16(3):243-53. DOI: 10.1111/1756-185X.12132. View

4.
Ito Y, Usui T, Kobayashi S, Iguchi-Hashimoto M, Ito H, Yoshitomi H . Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis. Arthritis Rheum. 2009; 60(8):2294-303. DOI: 10.1002/art.24687. View

5.
Yang J, Yang X, Chu Y, Li M . Identification of Baicalin as an immunoregulatory compound by controlling T(H)17 cell differentiation. PLoS One. 2011; 6(2):e17164. PMC: 3040219. DOI: 10.1371/journal.pone.0017164. View